Tag Archives: European Medicines Agency (EMA)

EMA Approves Dupixent as First-Ever Treatment for Young Children with Eosinophilic Esophagitis in the EU

(IN BRIEF) The European Medicines Agency has approved Dupixent as the first treatment for eosinophilic esophagitis (EoE) in young children aged one to 11, marking a significant step in managing this condition in a critical developmental phase. The approval is … Read the full press release

Bayer: Viralgen Vector Core Licensed for Large-Scale recombinant adeno-associated virus (rAAV) Gene Therapy Production

(PRESS RELEASE) SAN SEBASTIAN, Spain, 9-Jan-2023 — /EuropaWire/ — Bayer (ETR: BAYN), a global enterprise with core competencies in the life science fields of healthcare and nutrition and and one of the largest pharmaceutical companies in the world, has announced … Read the full press release

Professor Guido Rasi appointed Executive Director of the European Medicines Agency (EMA)

Executive Director appointed for five-year term LONDON, 20-11-2015 — /EuropaWire/ — Professor Guido Rasi has taken office as Executive Director of the European Medicines Agency (EMA) today. Professor Rasi was nominated as Executive Director for a five-year mandate by the … Read the full press release